These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of a meal and its composition on the bioavailability of betaxolol administered orally to healthy subjects. Thiercelin JF; Bianchetti G; Larribaud J; Ganansia J; Deves C; Trocherie S; Abriol C; Morselli PL World Rev Nutr Diet; 1984; 43():183-6. PubMed ID: 6147938 [No Abstract] [Full Text] [Related]
3. Pharmacokinetics of the new beta-adrenoceptor blocking agent betaxolol (SL 75212) in man after repeated oral administration. Bianchetti G; Blatrix C; Gomeni R; Kilborn JR; Larribaud J; Lücker PW; Thebault JJ; Trocherie S; Morselli PL Arzneimittelforschung; 1980; 30(11):1912-6. PubMed ID: 6109538 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of adimolol after single and multiple dose administration in healthy volunteers. Wiedemann I; Peil H; Justus H; Adamus S; Brantl V; Lohmann H Arzneimittelforschung; 1985; 35(6):964-9. PubMed ID: 2862877 [TBL] [Abstract][Full Text] [Related]
5. [The pharmacokinetics of 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane (talinolol, Cordanum, 02-115) 2. Excretion, blood level and distribution of the 14C-labeled compound in the rat]. Klemm W; Wenzel A Pharmazie; 1975 Oct; 30(10):675-7. PubMed ID: 695 [No Abstract] [Full Text] [Related]
6. Blood concentrations and pharmacodynamic effects of betaxolol (SL 75212) a new beta-adrenoceptor antagonist after oral and intravenous administration. Warrington SJ; Turner P; Kilborn JR; Bianchetti G; Morselli PL Br J Clin Pharmacol; 1980 Nov; 10(5):449-52. PubMed ID: 6108127 [TBL] [Abstract][Full Text] [Related]
7. Basic pharmacokinetics of bisoprolol, a new highly beta 1-selective adrenoceptor antagonist. Leopold G; Pabst J; Ungethüm W; Bühring KU J Clin Pharmacol; 1986; 26(8):616-21. PubMed ID: 2878941 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and absolute bioavailability of carteolol, a new beta-adrenergic receptor blocking agent. Ishizaki T; Ohnishi A; Sasaki T; Kushida K; Horai Y; Chiba K; Suganuma T Eur J Clin Pharmacol; 1983; 25(1):95-101. PubMed ID: 6137389 [TBL] [Abstract][Full Text] [Related]
9. Absolute bioavailability and dose proportionality of betaxolol in normal healthy subjects. Ludden TM; Boyle DA; Gieseker D; Kennedy GT; Crawford MH; Ludden LK; Clementi WA J Pharm Sci; 1988 Sep; 77(9):779-83. PubMed ID: 2906367 [TBL] [Abstract][Full Text] [Related]
10. [Pharmacology and clinical pharmacokinetics of nadolol]. Lazowski J; Wegrzyn B; Lypka A Pol Tyg Lek; 1981 Sep; 36(39):1521-4. PubMed ID: 6121320 [No Abstract] [Full Text] [Related]
11. Metabolic studies in patients with nadolol: oral and intravenous administration. Dreyfuss J; Brannick LJ; Vukovich RA; Shaw JM; Willard DA J Clin Pharmacol; 1977; 17(5-6):300-7. PubMed ID: 16040 [TBL] [Abstract][Full Text] [Related]
12. Betaxolol kinetics in hypertensive children with normal and abnormal renal function. Palminteri R; Assael BM; Bianchetti G; Gomeni R; Claris-Appiani A; Edefonti A; Morselli PL Clin Pharmacol Ther; 1984 Feb; 35(2):141-7. PubMed ID: 6692644 [TBL] [Abstract][Full Text] [Related]
13. Cardiovascular effects of single oral doses of the new beta-adrenoceptor blocking agents betaxolol (SL 75212) in healthy volunteers. Cadigan PJ; London DR; Pentecost BL; Bianchetti G; Gomeni R; Kilborn JR; Morselli PL Br J Clin Pharmacol; 1980 Jun; 9(6):569-75. PubMed ID: 6104498 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of the new beta-adrenoceptor blocker SL 75212 in man after repeated oral administration [proceedings]. Bianchetti G; Blatrix C; Gomeni R; Kilborn JR; Larribaud J; Lücker PW; Morselli PL; Thébault JJ; Trocherie S Br J Clin Pharmacol; 1979 Oct; 8(4):408P. PubMed ID: 41560 [No Abstract] [Full Text] [Related]
15. Pharmacokinetics of nadolol, a beta-receptor antagonist: administration of therapeutic single- and multiple-dosage regimens to hypertensive patients. Dreyfuss J; Griffith DL; Singhvi SM; Shaw JM; Ross JJ; Vukovich RA; Willard DA J Clin Pharmacol; 1979; 19(11-12):712-20. PubMed ID: 43870 [No Abstract] [Full Text] [Related]
16. Beta-adrenoceptor blocking effects and pharmacokinetics of betaxolol (SL 75212) in man. Giudicelli JF; Chauvin M; Thuillez C; Richer C; Bianchetti G; Gomeni R; Morselli PL Br J Clin Pharmacol; 1980 Jul; 10(1):41-9. PubMed ID: 6104973 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and biopharmaceutics of some adrenergic beta-receptor antagonists with special emphasis on alprenolol and metoprolol. Regårdh CG Acta Pharmacol Toxicol (Copenh); 1975; 37(1):1-39. PubMed ID: 237402 [No Abstract] [Full Text] [Related]
18. Pharmacokinetics and pharmacodynamics of mepindolol sulphate. Bonelli J; Hitzenberger G; Krause W; Wendt H; Speck U Int J Clin Pharmacol Ther Toxicol; 1980 Apr; 18(4):169-76. PubMed ID: 6103882 [TBL] [Abstract][Full Text] [Related]